PAH: Risk Reduction Strategies Using Single and Combination Therapies

Target Audience
This activity is intended for pulmonologists, cardiologists, primary care providers, and other health care providers who manage patients with PAH.

Program Overview
This activity will cover how to develop an effective clinical risk-reduction strategy with single or combined drugs for patients with PAH.

Learning Objectives
Upon completion of this activity, participants should be better able to:

Develop an effective clinical risk-reduction strategy with single or combined drugs for patients with PAH
Review the evidence for initiating combination therapy in patients with PAH
Review current and emerging treatment options for patients with PAH
Align treatment strategy to risk level using single or combined drug therapies for patients with PAH
Discuss strategies to effectively identify side effects, optimize therapy, and improve outcomes for patients with PAH
Apply patient-specific considerations to individualize care for patients with PAH